Mpox in Africa: one year continental response outcomes and way forward
Open Access
- 15 September 2026
- journal article
- Published by BMJ in BMJ Global Health
- Vol. 11 (9) , e023050
Abstract
Background: Following the declaration of mpox as both a global and continental public health emergency in August 2024, the Joint Incident Management Support Team (IMST), co-led by the Africa Centres for Disease Control and Prevention (Africa CDC) and the WHO, was activated in Kinshasa, DRC to coordinate the continental mpox response. This article highlights the first year’s epidemiological and operational findings. Methods: Key performance indicators across eight IMST pillars (coordination, surveillance, laboratory, case management, infection prevention and control, risk communication and community engagement (RCCE), vaccination and research) were descriptively analysed using data from 28 African Union Member States from January 2024 to August 2025. Results: A total of 49 803 confirmed cases and 240 deaths (CFR 0.5%) were recorded across 28 countries. The response was supported with US$977 million as tracked by the IMST. Operational achievements included 87% surveillance completeness, 72% contact tracing completeness and improved average laboratory turnaround time from >5 days to 2 days. Laboratory testing capacity expanded from 2 to 27 sites in the DRC and from 1 to 56 decentralised sites in Burundi. RCCE activities reached 50 million people in 21 countries, with vaccine acceptance among high-risk groups rising from 44% to 87%. Operational research achievements included a responsive and functional research coordination mechanism, 24 (92%, 24/26) multi-country clinical and operational research studies implemented and 60% completion rate of the research data and material sharing framework for Africa. Only 938 000 doses (32%) of the 3.1 million vaccine doses delivered were administered. Conclusion: The joint continental IMST is a new benchmark for response governance, successfully mobilising resources and scaling up diagnostics under unified co-leadership. On the other hand, the evaluation revealed persistent structural challenges in last-mile vaccine delivery, contact tracing (due to stigma/funding) and weak regional collaborative research including fragmented regional research priorities. Future focus must shift from emergency action to durable, sustained investment in national and sub-national health security architecture using a multisectoral whole of government approach.Keywords
This publication has 21 references indexed in Scilit:
- Evaluation of a decentralised model of care on case isolation and patient outcomes during the 2018–20 Ebola outbreak in the Democratic Republic of the Congo: a retrospective observational studyThe Lancet Global Health, 2025
- Implementation of a cascade training model to enhance emergency care capacity of healthcare workers during the COVID-19 outbreak in UgandaAfrican Journal of Emergency Medicine, 2025
- Mpox continues to spread in Africa and threatens global health securityNature Medicine, 2024
- The role of Africa Centres for Disease Control and Prevention during response to COVID-19 pandemic in Africa: lessons learnt for future pandemics preparedness, prevention, and responseBMJ Global Health, 2024
- Lessons identified for a future pandemicJournal of Antimicrobial Chemotherapy, 2023
- Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022New England Journal of Medicine, 2022
- Combating the COVID-19 infodemic: a three-level approach for low and middle-income countriesBMJ Global Health, 2021
- Test sensitivity is secondary to frequency and turnaround time for COVID-19 screeningScience Advances, 2021
- Diagnosis of Ebola Virus Disease: Past, Present, and FutureClinical Microbiology Reviews, 2016
- After Ebola in West Africa — Unpredictable Risks, Preventable EpidemicsNew England Journal of Medicine, 2016